Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
09/2010
09/21/2010US7799915 Several exemplified (pyrimidin-2-ylamino)benzenesulfonamide compounds such as N-phenyl-4-[(4-thien-2-ylpyrimidin-2-yl)amino]benzenesulfonamide; I kappa B kinase inhibitors (IKK inhibitors); anticancer agents, autoimmune diseases, osteoporosis
09/21/2010US7799827 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
09/21/2010US7799818 Pyrazole derivatives, compositions containing such compounds and methods of use
09/21/2010US7799782 P38 inhibitors and methods of use thereof
09/21/2010US7799778 5-substituted 2-aminopyridine analogs for treating allergic and inflammatory diseases
09/21/2010US7799773 administering 7-Benzyloxy-3-cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine, for the treatment of Alzheimer's disease, cognitive impairment, dementia, epilepsy, neuropathic pain, Parkinson's disease, schizophrenia, attention deficit disorder or depression in humans
09/21/2010CA2566945C Pyrazole derivatives, compositions containing such compounds and methods of use
09/21/2010CA2538884C Quinazoline derivatives as tyrosine kinase inhibitors
09/21/2010CA2440559C Novel non-imidazole compounds
09/21/2010CA2436225C N-(arylsulphonyl)beta-amino acid derivatives comprising a substituted aminomethyl group, process for preparing them and pharmaceutical compositions containing them
09/21/2010CA2434178C Substituted amine derivatives and methods of use
09/21/2010CA2428019C Estrogen receptor modulators
09/21/2010CA2417148C Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
09/21/2010CA2401502C Carboxylic acid derivatives as ip antagonists
09/21/2010CA2359948C Triazole compounds with dopamine-d3-receptor affinity
09/21/2010CA2290614C Process for the preparation of polymers having nucleobases as side groups
09/16/2010WO2010104721A1 Mineralocorticoid receptor antagonist and methods of use
09/16/2010WO2010104406A1 Prodrug forms of kinase inhibitors and their use in therapy
09/16/2010WO2010104194A1 Benzofuran derivatives
09/16/2010WO2010104124A1 Method for fluorescently labeling protein
09/16/2010WO2010103437A1 Benzofuranyl derivatives used as glucokinase inhibitors
09/16/2010WO2010103297A2 Bis aromatic compounds for use as ltc4 synthase inhibitors
09/16/2010WO2010103279A1 Bis aromatic compounds for use as lct4 synthase inhibitors
09/16/2010WO2010103278A1 Bis aromatic compounds for use as ltc4 synthase inhibitors
09/16/2010WO2010102809A1 Substituted nicotinamides as kcnq2/3 modulators
09/16/2010WO2010077836A3 Pyrrolidine compounds which modulate the cb2 receptor
09/16/2010WO2010065865A3 Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
09/16/2010US20100234435 Cycloalkylamino acid derivatives
09/16/2010US20100234428 Substituted 2-mercapto-3-aminopyridines as kcnq2/3 modulators
09/16/2010US20100234395 Ureide derivative and pharmaceutical application thereof
09/16/2010US20100234391 N-substituted piperazines
09/16/2010US20100234357 Benzofuran derivatives
09/16/2010US20100234355 Isoquinoline derivatives and their use as inhibitors of cytokine mediated diseases
09/16/2010US20100234354 Pyridazinone derivatives
09/16/2010US20100234353 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
09/16/2010US20100234350 Platelet adp receptor inhibitors
09/16/2010US20100234348 Compositions and methods for potentiating antibiotic activity
09/16/2010US20100234311 Methicillin-Resistant Staphylococcus Aureus Active Metabolites
09/16/2010US20100234220 Oxooxetanes as Fungicidal Agents
09/16/2010US20100233106 Small-molecule modulators of melanin expression
09/16/2010US20100230648 Chromene Compounds
09/16/2010CA2754998A1 Substituted nicotinamides as kcnq2/3 modulators
09/16/2010CA2754946A1 Bis aromatic compounds for use as ltc4 synthase inhibitors
09/16/2010CA2754936A1 Bis aromatic compounds for use as ltc4 synthase inhibitors
09/16/2010CA2754904A1 Benzofuran derivatives
09/16/2010CA2754808A1 Prodrug forms of kinase inhibitors and their use in therapy
09/16/2010CA2754781A1 Bis aromatic compounds for use as ltc4 synthase inhibitors
09/16/2010CA2754681A1 Benzofuranyl derivatives used as glucokinase inhibitors
09/16/2010CA2751901A1 Mineralocorticoid receptor antagonist and methods of use
09/15/2010EP2228373A1 METHOD FOR PRODUCING 4'-ETHYNYL d4T
09/15/2010EP2228364A1 Acylsulfonamides as inhibitors of steroid sulfatase
09/15/2010EP2228065A2 Heterocyclo inhibitors of potassium channel function
09/15/2010EP2227770A2 Prolyl hydroxylase inhibitors
09/15/2010EP2227456A2 Hedgehog pathway antagonists and therapeutic applications thereof
09/15/2010EP2227452A2 Pyridine compounds
09/15/2010EP2079690B1 3-aza-bicyclo[3.1.0]hexane derivatives
09/15/2010EP1910314B1 Benzimidazole derivatives for treatment of inflammatory diseases
09/15/2010EP1569908B1 Pyridine n-oxide compounds as phosphodiesterase 4 inhibitors
09/15/2010CN101835756A 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive mglur2 -receptor modulators
09/15/2010CN101830937A Visualized double-reaction tube fluorine-18 multifunctional automated synthesis module
09/15/2010CN101830891A Synthesizing method of piribedil
09/15/2010CN101830890A Novel process for the preparation of 2H-chromenes
09/15/2010CN101830855A Substituted nitrogen-containing benzoheterocycle compounds and preparation method and application thereof
09/14/2010US7795447 4-(Acylaminoacetylamino)imidazole derivatives, e.g., methyl 3-(4-{2-[2-(3,5-Difluorophenyl)acetylamino]pentanoylamino}imidazol-1-yl)butyrate; treating neurodegenerative and/or neurological disorders such as Alzheimer's disease and Down's Syndrome
09/14/2010US7795440 N-substituted tricyclic 1-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders
09/14/2010US7795280 3-(2-Nitro-phenylsulfanyl)-1-pyridin-2-ylmethyl-1H-indole-6-carbonitrile, used for the treatment of benign prostate hyperplasia, bone disorders, female sexual dysfunction,, atherosclerosis, anemia, muscular atrophy, as contraceptives or for hormone replacement therapy
09/14/2010US7795278 Substituted tetrahydro-2H-isoquinolin-1-one derivatives, and methods for the production and use thereof
09/14/2010US7795272 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
09/14/2010US7795271 Substituted pyrimidinones
09/14/2010US7795270 3-benzoyl-1-[(Z)-4-(trityloxy)-2-butenyl]-1,2,3,4-tetrahydro-2,4-pyrimidinedione; antiprotozoa agents; Deoxyuridine triphosphate nucleotidohydrolase inhibitors; malaria
09/14/2010US7795265 such as 3-(4-{[1-(3-ethoxyphenyl)-2-(4-methylphenyl)-1H-imidazol-4-yl]carbonyl}-1-piperazinyl)-1-naphthoic acid, used for the treatment of obesity or diabetes
09/14/2010US7795261 substance P receptor blockers, such as [2R-trans]-{2-benzyl-4-[4-(1-pyrazin-2-yl-pyrrolidin-3-yl)-piperazin-1-yl]-piperidin-1-yl}-(3,5-bis-trifluoromethyl-phenyl)-methanone, used for treating schizophrenia, emesis, anxiety and depression, irritable bowel syndrome, sleep disorders, pain and inflammation
09/14/2010US7795250 Indole derivatives as antiviral agents
09/14/2010US7795229 beta-lactam compounds having a C-glycoside in the molecule, in combination with a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor selected from atorvastatin and rosuvastatin; synergistic
09/14/2010CA2549431C Optically active quaternary ammonium salt having axial asymmetry and process for producing .alpha.-amino acid and derivative thereof with the same
09/14/2010CA2441501C Rho-kinase inhibitors
09/14/2010CA2314771C Method for manufacturing aminoalcohol
09/10/2010WO2010101246A1 Piperidine and pyrrolidine derivatives having npy y5 receptor antagonism
09/10/2010WO2010101128A1 Amide compound
09/10/2010WO2010101127A1 Indole compound
09/10/2010WO2010100475A1 Hydroxamic acid derivatives as gram-negative antibacterial agents
09/10/2010WO2010100255A1 Pharmaceutical hypocholesterolemic compositions
09/10/2010WO2010100178A1 Heterocyclic antiviral compounds
09/10/2010WO2009118765A8 Novel monoamine re-uptake inhibitor
09/10/2010CA2754384A1 Pharmaceutical hypocholesterolemic compositions
09/10/2010CA2753730A1 Inhibitors of beta-secretase
09/10/2010CA2752443A1 Heterocyclic antiviral compounds
09/09/2010US20100228035 Functionalized Ionic Liquids, and Methods of Use Thereof
09/09/2010US20100226918 Pyrrole derivatives as p2y12 antagonists
09/09/2010US20100226879 Heterocyclic antiviral compounds
09/08/2010EP2226315A1 2-aminoquinazoline derivative
09/08/2010EP2225230A1 Solid forms of 3-(6-(1-(2,2-difluorobenzoýd¨ý1,3¨dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
09/08/2010EP2225229A1 Pyrazole derivatives as 5-lo inhibitors
09/08/2010EP2225228A2 Method of obtaining of 4-n-furfurylcytosine and/or its derivatives, an anti-aging composition and use of 4-n-furfurylcytosine and/or its derivatives in the manufacture of anti-aging composition
09/08/2010EP2225211A1 Herbicidal pyridazinone derivatives
09/08/2010EP1841741B1 Piperidine derivatives as prodrugs of potassium channel inhibitors
09/08/2010EP1693358B1 Process for producing epoxytriazole compound and intermediate therefor
09/08/2010EP1478624B1 Chemical compounds
09/08/2010EP0882717B1 Nitrogenous heterocyclic compounds
09/08/2010CN1968929B Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicaments
1 ... 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 ... 694